Product image of Levomin 30 (Ethinylestradiol, Levonorgestrel) supplied by GNH India

Levomin 30

Active Ingredient:
Ethinylestradiol, Levonorgestrel
Origin:
EU

Levomin 30 (Ethinylestradiol, Levonorgestrel)

Ethinylestradiol / Levonorgestrel, the active ingredient in Levomin 30, is a combined oral contraceptive presented as a tablet for oral use. It works by preventing ovulation, thickening cervical mucus and altering the endometrium to inhibit implantation, thereby providing reliable birth control for women of reproductive age.

GNH India supplies Levomin 30 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑assured products that meet EU regulatory standards, and reliable distribution channels with responsive customer support.

Manufacturer / TM Owner

Mibe Gmbh Arzneimittel

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Levomin 30, a combined oral contraceptive, is indicated for hormonal contraception in women.

  • Contraception: Prevents pregnancy by inhibiting ovulation and creating cervical mucus changes.
  • Menstrual cycle regulation: Helps establish regular menstrual bleeding patterns.
  • Acne treatment: Reduces androgen‑driven skin lesions in women when other therapies are insufficient.

How It Works

  • Ethinylestradiol and levonorgestrel bind to estrogen and progesterone receptors, respectively, suppressing the hypothalamic‑pituitary‑gonadal axis. This reduces the secretion of luteinizing hormone (LH) and follicle‑stimulating hormone (FSH), preventing follicular development and ovulation. The progestogenic component also thickens cervical mucus and induces endometrial changes that make implantation unlikely.

Side Effects

Levomin 30 may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Headache: tension‑type or migraine‑like pain.
  • Breast tenderness: temporary swelling or discomfort.
  • Irregular bleeding: spotting between periods.
  • Weight gain: modest fluid retention.
  • Mood changes: mild irritability or emotional fluctuations.

Serious or Rare Side Effects

  • Venous thromboembolism: deep‑vein thrombosis or pulmonary embolism.
  • Stroke or myocardial infarction: especially in smokers over 35.
  • Severe hypertension: sudden increase in blood pressure.
  • Liver dysfunction: jaundice or abnormal liver enzymes.
  • Allergic reactions: rash, itching, or swelling of the face.
  • Visual disturbances: sudden loss of vision or eye pain.

Precautions & Warnings

Before prescribing Levomin 30, clinicians should evaluate patient history and risk factors.

  • Smoking status: avoid use in women over 35 who smoke.
  • Cardiovascular disease: assess for history of thromboembolic events.
  • Liver disease: contraindicated in active hepatic impairment.
  • Migraine with aura: consider alternative contraception.
  • Pregnancy testing: confirm non‑pregnant status before initiation.
  • Store at room temperature: keep in the original pack, protect from moisture and heat.

Avoid Interactions

Levomin 30 can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid)

  • Antiepileptics (e.g., carbamazepine, phenytoin): may reduce contraceptive effectiveness.
  • Rifampin and other strong enzyme inducers: significantly lower hormone levels.
  • Certain HIV protease inhibitors: can increase hormone concentrations.

Moderate Interactions (Monitor Closely)

  • Antifungal agents (e.g., ketoconazole): may increase hormone levels.
  • St. John’s Wort: may modestly reduce efficacy.
  • Antibiotics (e.g., tetracycline): generally minimal effect but monitor for breakthrough bleeding.

Frequently Asked Questions

Levomin 30 is a combined oral contraceptive containing ethynylestradiol and levonorgestrel. It is prescribed to prevent pregnancy in women of reproductive age and may also be used to regulate menstrual cycles or treat moderate acne when indicated by a healthcare professional.

The estrogen component (ethynylestradiol) and the progestogen (levonorgestrel) act on the hypothalamic‑pituitary‑ovarian axis, suppressing luteinizing hormone and follicle‑stimulating hormone release. This blocks ovulation, thickens cervical mucus, and alters the endometrium, creating conditions that prevent fertilisation and implantation.

The dosing regimen for Levomin 30 is determined by the prescribing clinician. Typically, it is taken once daily at the same time for a 21‑day active phase followed by a hormone‑free interval, but the exact schedule should follow the prescriber’s instructions.

Levomin 30 is intended for use only when a woman is not pregnant. If pregnancy occurs, the product should be discontinued and medical advice sought. During breastfeeding, combined oral contraceptives are generally considered compatible, but clinicians may prefer progestogen‑only options for certain situations.

To place an order, submit an enquiry on the Levomin 30 product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levomin 30 contains the standard dose of ethynylestradiol combined with levonorgestrel, a widely used progestogen. Compared with formulations that use newer progestins, it offers a well‑characterised efficacy and safety profile, but individual tolerability may vary, making clinician‑guided selection important.

Levomin 30 tablets should be stored at room temperature, below 25 °C, in their original blister pack. Protect them from excess moisture, direct sunlight and heat to maintain potency throughout the shelf life.

Levomin 30 is taken orally, usually as a single tablet each day at the same time. Patients should follow the prescribed cycle, typically 21 consecutive active tablets followed by a hormone‑free interval, unless otherwise directed by their healthcare provider.

Serious risks include venous thromboembolism, stroke, myocardial infarction, and severe hypertension, particularly in smokers over 35 or women with pre‑existing cardiovascular conditions. Prompt medical attention is required if symptoms such as chest pain, sudden shortness of breath, severe headache, or leg swelling occur.

Levomin 30 is contraindicated in women who are pregnant, have a history of thromboembolic disorders, uncontrolled hypertension, active liver disease, known or suspected breast cancer, or who are smokers aged 35 years or older. A thorough medical assessment is essential before initiation.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ethinylestradiol, Levonorgestrel

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT